GASTROINTESTINAL STROMAL NEOPLASM
Clinical trials for GASTROINTESTINAL STROMAL NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new GASTROINTESTINAL STROMAL NEOPLASM trials appear
Sign up with your email to follow new studies for GASTROINTESTINAL STROMAL NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for GIST patients: drug combo targets resistant tumors
Disease control Recruiting nowThis early-phase trial is testing a new combination of two drugs—ziftomenib and imatinib—in adults with advanced gastrointestinal stromal tumors (GIST) that have stopped responding to imatinib alone. The study will first find a safe dose, then check if the combination can shrink …
Matched conditions: GASTROINTESTINAL STROMAL NEOPLASM
Phase: PHASE1 • Sponsor: Kura Oncology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Scientists launch major effort to unlock secrets of rare stomach cancer
Knowledge-focused Recruiting nowThis study follows 400 people aged 6 and older who have a rare stomach cancer called GIST. Researchers will collect tumor tissue during surgery and study it in the lab to learn more about the disease. Participants are monitored every 6 to 12 months for up to 10 years before surge…
Matched conditions: GASTROINTESTINAL STROMAL NEOPLASM
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC